Khosla Ventures

Khosla Ventures, founded in 2004 and headquartered in Menlo Park, California, is a venture capital firm that provides strategic advice, capital, and support to bold entrepreneurs across various sectors. The firm focuses on early-stage investments in areas such as artificial intelligence, climate technology, sustainability, enterprise solutions, consumer products, fintech, digital health, medical technology, and therapeutics. Khosla Ventures is particularly interested in innovative solutions that address significant socio-economic challenges and enhance productivity, especially for low-income populations and small businesses in emerging markets. The firm embraces experimentation and is open to investing in unconventional and high-risk ventures, often acting as the sole investor in groundbreaking projects. With a commitment to fostering impactful entrepreneurship, Khosla Ventures seeks to create value through technological advancements and creative business models, with a special emphasis on markets in South Asia.

Bruce Armstrong

Partner

Alex Bentley

Partner and Investor

Blignaut, Ryno

Operating Partner

Alice Brooks

Principal

Peter Buckland

General Partner and COO

Byun, Brian

Venture Partner

Catherine Casuga

Operating Partner

Jon Chu

Partner and Investor

Ece Erdagoz

Principal

Bryan Gartner

Partner

Kanu Gulati

Partner

Judy Huang

Operating Partner

Khosla, Vinod

Managing Director

Kelly Kinnard

Operating Partner

Alexander Morgan

Partner

Arash Rebek JD

Partner, Capital Formation

Jessy Rivest

Partner and Investor

Scanlan, Leah

Operating Partner

Nikita Shamgunov

Partner

Sven Strohband Ph.D

Managing Director

Rajesh Swaminathan

Partner

David Weiden

Managing Director

Ece Wyrick

Principal and Investor

Adam Coates Ph.D

Operating Partner

Kanupriya Gulati Ph.D

Partner and Investor

Past deals in Health Care

Loop

Series B in 2022
By using data, technology, and high quality medical expertise, we aim to deliver an empathetic people-centric healthcare experience that helps people live longer.

Faeth Therapeutics

Seed Round in 2022
Faeth Therapeutics is a data-driven, evidence-based company that specializes in mechanistic understanding of the way that dietary nutrients influence tumor growth and cancer treatment. It fully focuses on matching specific diets with tumor genotypes and treatment regimens to improve the outcomes of cancer therapy. The company was founded to translate breakthrough discoveries, made by cancer research laboratories, into clinical practice. Its founding team includes some of the industry’s preeminent researchers and clinicians.

Robin Healthcare

Series B in 2021
Robin Healthcare provides medical scribe services. They help remove barriers to health and improve the doctor-patient experience. They offer technology and trained medical scribes to deliver a seamless experience that integrates directly into the electronic medical record, taking on the administrative burdens of medicine so doctors can reclaim their time and maintain control over their practice.

Sword Health

Series D in 2021
Sword Health is on a mission to free 2 billion people from pain by pioneering the field of AI Care. It is #1 in clinical and cost-saving outcomes because we have the most advanced AI, developed and overseen by the most clinically rigorous team. Sword has developed the first platform to predict, prevent, and treat pain by starting with the expertise of world-class doctors of physical therapy and then building an interactive AI experience to deliver care that members can use anywhere, anytime, under a clinician’s supervision.

Loop

Series A in 2021
By using data, technology, and high quality medical expertise, we aim to deliver an empathetic people-centric healthcare experience that helps people live longer.

House Rx

Seed Round in 2021
House Rx is a health technology platform focused on improving affordability and patient access to specialty medications.

Connie Health

Series A in 2021
Connie Health is a provider of medical advisory services focused on enhancing the experience of older Americans in navigating Medicare decision-making. The company utilizes an AI-driven technology platform, complemented by local Medicare experts, to assist individuals in maximizing their insurance benefits, optimizing prescription costs, and identifying healthcare providers in their vicinity. By offering personalized support, Connie Health empowers seniors to make informed healthcare choices, select the most appropriate healthcare plans, and effectively understand the benefits of their insurance coverage.

Even

Seed Round in 2021
Even is a health tech company and healthcare provider that partners directly with the top hospitals in the country to offer you unlimited diagnostics, consultations, and 50 lakh worth of hospitalisations all with one monthly subscription cost.

Sword Health

Series C in 2021
Sword Health is on a mission to free 2 billion people from pain by pioneering the field of AI Care. It is #1 in clinical and cost-saving outcomes because we have the most advanced AI, developed and overseen by the most clinically rigorous team. Sword has developed the first platform to predict, prevent, and treat pain by starting with the expertise of world-class doctors of physical therapy and then building an interactive AI experience to deliver care that members can use anywhere, anytime, under a clinician’s supervision.

Ellipsis Health

Series A in 2021
Ellipsis Health is an early-stage start-up developing affective computing for existing patient/care team interactions to create a real-time, behavioral health vital sign for each patient. It provides a simple, cost-effective way for health systems to continually screen their patient population for conditions such as depression and get patients the support they need.

Catch

Venture Round in 2021
Catch is redesigning benefits to put people at the center of their own financial stability and security. For freelancers, contractors, and workers without access to employer benefits, Catch automatically handles tax withholding, builds long-term investment savings, and provides critical insurance products. In creating a personalized safety net, Catch envisions a world where individuals can leverage data-driven curation and timely insights to gain full agency over changing needs.
Mars is a men's wellness brand. The company provides hair, beard, skin, performance and wellness products. Mars was established on January 31, 2021 by Samarth Sindhi in Hyderabad, Andhra Pradesh.

Hello Heart

Series C in 2021
Hello Heart is a best in class solution that empowers people to understand and improve their heart health - the #1 cost factor for employers. The program is clinically based and targets people with high blood pressure. Each of our users receives a wireless blood pressure monitor and real-time personalized tips on their smartphone. It is easy to use and helps participants improve their heart health in a fun and engaging way.

Level

Series A in 2021
Level is a technology company that makes financial products for employers. With Level, everyone benefits: employers offer bigger benefits for less, members get more freedom and choice, and providers are paid instantly. Level makes paying with benefits as simple as paying with cash. The company was founded in 2018 and is based in New York, New York.

Rightway

Series C in 2021
Rightway is a leading technology and services company radically simplifying healthcare for clients and members. Its Care Navigation and new-to-the world PBM platform reimagine the member experience, generate industry-leading engagement, and significantly reduce total cost-of-care.

Forward

Series D in 2021
Forward is a startup redesigning the way healthcare is delivered using all the technologies healthcare has neglected such as sensors, mobile, and AI. Forward was founded in January 2016 by former executives and engineering leaders from Google and Uber and led by serial entrepreneur Adrian Aoun. Forward is funded by investors and entrepreneurs including First Round Capital, Eric Schmidt (Google/Alphabet chairman), Marc Benioff (Salesforce founder), Joe Lonsdale (Palantir founder), Joshua Kushner (Oscar co-founder), and Garrett Camp (Uber co-founder).

Sword Health

Series B in 2021
Sword Health is on a mission to free 2 billion people from pain by pioneering the field of AI Care. It is #1 in clinical and cost-saving outcomes because we have the most advanced AI, developed and overseen by the most clinically rigorous team. Sword has developed the first platform to predict, prevent, and treat pain by starting with the expertise of world-class doctors of physical therapy and then building an interactive AI experience to deliver care that members can use anywhere, anytime, under a clinician’s supervision.

Lumiata

Series B in 2021
Lumiata is transforming the healthcare enterprise through the application of AI. Bringing predictive power within reach of data science teams and business users, we’re driving predictability and precision at scale — empowering providers and payers to reduce risk and manage costs and move out of reliance on flat data into a future of insights. Lumiata machine learning tools and pre-trained models comprise a scalable platform purpose-built for healthcare. Lumiata products are built from more than 120 million patient records, in-depth clinical knowledge, and its proprietary clinical IP. Lumiata enables healthcare organizations to explore use cases such as underwriting and care management. Lumiata is proud to be backed by Khosla Ventures, Blue Venture Fund, Defy.vc, and AllegisNL Capital. Team Lumiata is distributed across Silicon Valley, Dallas, and Guadalajara, Mexico.

Oscar Health

Venture Round in 2020
Oscar Health is a health insurance company that offers a range of plans for individuals, families, and small groups, as well as Medicare Advantage options for adults aged 65 and older. Founded in 2012 by Joshua Kushner, Kevin Nazemi, and Mario Schlosser, the company is headquartered in New York City. Oscar Health employs technology and data-driven solutions to enhance the healthcare experience, providing virtual care, doctor support, and appointment scheduling services. Its plans are available in select regions of New York, New Jersey, California, and Texas, catering to those who do not receive employer-sponsored health insurance.

Curai Health

Series B in 2020
Curai is a virtual care company that uses artificial intelligence to provide chat-based primary care at a lower cost. It aims to make affordable, high-quality primary care accessible to everyone on the planet, whenever they want it. Founded by Neal Khosla and Xavier Amatriain in 2017, Curai Health offers chat-based primary care that combines clinicians with the industry's most advanced AI to create a learning healthcare system that increasingly slashes the cost of delivering high-quality care. Headquartered in Palo Alto, Curai Health is available directly to consumers or through enterprise partnerships.

Caption Health

Series B in 2020
Caption Health, Inc. is a technology company that specializes in artificial intelligence-driven software solutions for ultrasound examinations. Founded in 2013 and headquartered in Brisbane, California, the company offers Caption AI, a system designed to assist healthcare providers in acquiring and interpreting ultrasound images. This software provides real-time guidance during exams, automates quality assessments, and facilitates the interpretation of ultrasound results, enabling practitioners to capture high-quality diagnostic images more efficiently. As the adoption of the Caption AI platform grows, Caption Health plans to enhance its technology and expand its clinical capabilities, aiming to integrate its solutions into a wider range of healthcare settings.

Oscar Health

Venture Round in 2020
Oscar Health is a health insurance company that offers a range of plans for individuals, families, and small groups, as well as Medicare Advantage options for adults aged 65 and older. Founded in 2012 by Joshua Kushner, Kevin Nazemi, and Mario Schlosser, the company is headquartered in New York City. Oscar Health employs technology and data-driven solutions to enhance the healthcare experience, providing virtual care, doctor support, and appointment scheduling services. Its plans are available in select regions of New York, New Jersey, California, and Texas, catering to those who do not receive employer-sponsored health insurance.

Siren Care

Series B in 2020
Siren Care is engaging with providers and payers to transform healthcare for chronic disease and aging. Our flagship program, the Siren Diabetic Foot Program, is a comprehensive service powered by our proprietary Siren Socks which monitor foot temperature continuously to deliver superior early detection of diabetic foot ulcers.

Yes Health

Series A in 2020
Yes Health is an all-mobile diabetes prevention program designed to empower people everywhere to start living healthier, happier lives. Its team is consists of physicians, health coaches and engineers that created a high-engagement program that’s low-cost, easy to follow and successful in preventing the onset of diabetes. People already living with the disease can also use it to successfully manage their symptoms. Yes Health helps people take charge of their health—and have fun doing it—by developing healthy habits that last a lifetime. Its mission is to stop diabetes.

Sword Health

Series A in 2020
Sword Health is on a mission to free 2 billion people from pain by pioneering the field of AI Care. It is #1 in clinical and cost-saving outcomes because we have the most advanced AI, developed and overseen by the most clinically rigorous team. Sword has developed the first platform to predict, prevent, and treat pain by starting with the expertise of world-class doctors of physical therapy and then building an interactive AI experience to deliver care that members can use anywhere, anytime, under a clinician’s supervision.

Q Bio

Series B in 2020
Q Bio, founded in 2015 by Jeffrey Kaditz, Dr. Michael Snyder, and Dr. Garry Choy, operates a clinical digital twin platform aimed at assessing patients' medical histories to identify immediate and future health risks. Based in San Carlos, California, the company utilizes whole-body scans to create a digital twin of each patient's physical body, quantifying and digitizing health data. By leveraging simulated human physiology and machine learning, Q Bio's platform can predict potential health risks, enabling healthcare professionals to provide proactive treatment. The interdisciplinary team at Q Bio comprises experts in applied mathematics, computational physics, electrical engineering, genetics, and radiology, supported by prominent venture capital firms.

Iora Health

Series F in 2020
Iora Health is dedicated to providing possible service and care for each patient without any of the barriers or excuses that plague the current system. They’ve completely redesigned Primary Care to help patients better manage their health and navigate the health care system. Every patient gets a personal physician as well as a personal health coach who stays in close contact during and between office visits, both of whom are available by email, text, or video in addition to in-person visits. In addition, they provide educational offerings, including group visits, to help patients stay on track with their health goals.

Connie Health

Pre Seed Round in 2020
Connie Health is a provider of medical advisory services focused on enhancing the experience of older Americans in navigating Medicare decision-making. The company utilizes an AI-driven technology platform, complemented by local Medicare experts, to assist individuals in maximizing their insurance benefits, optimizing prescription costs, and identifying healthcare providers in their vicinity. By offering personalized support, Connie Health empowers seniors to make informed healthcare choices, select the most appropriate healthcare plans, and effectively understand the benefits of their insurance coverage.

Digi-Prex

Seed Round in 2019
Digi-Prex is a Chronic disease management platform that provides patients with a holistic solution to assist in the management of their conditions. We start by providing these patients with a subscription that allows them access to discounted medicines delivered to their home regularly and provides them access to a full service platform customized to their particular condition allowing them a one stop shop to assist in the management of their condition.

Ginger

Series C in 2019
Ginger.io, Inc. is a digital mental health provider that offers a behavioral analytics platform designed to deliver on-demand mental healthcare via mobile devices. Founded in 2010 and headquartered in San Francisco, California, the platform connects users with a team of behavioral health coaches, therapists, and psychiatrists, facilitating personalized care accessible 24/7. Users can collect and analyze both passive and active behavioral data, enabling the identification of health insights and deviations from normal behavior. This service is utilized by a wide range of clients, including researchers, healthcare providers, and millions of employees through partnerships with leading employers and health plans. Ginger's approach focuses on providing immediate support and evidence-based interventions for individuals experiencing mental health challenges such as depression and anxiety.

Careswitch

Seed Round in 2019
Careswitch is rethinking the home care industry to increase opportunities and wellbeing for all those involved. They provide a single software platform that streamlines and automates the operations of a home care company to enhance its efficiency. Care planning, scheduling, documentation, and payroll are handled by this surprisingly straightforward software. It also contains the sole carer app that has been shown to facilitate caregiving tasks and reduce errors.

Hello Heart

Series B in 2019
Hello Heart is a best in class solution that empowers people to understand and improve their heart health - the #1 cost factor for employers. The program is clinically based and targets people with high blood pressure. Each of our users receives a wireless blood pressure monitor and real-time personalized tips on their smartphone. It is easy to use and helps participants improve their heart health in a fun and engaging way.

Sword Health

Series A in 2019
Sword Health is on a mission to free 2 billion people from pain by pioneering the field of AI Care. It is #1 in clinical and cost-saving outcomes because we have the most advanced AI, developed and overseen by the most clinically rigorous team. Sword has developed the first platform to predict, prevent, and treat pain by starting with the expertise of world-class doctors of physical therapy and then building an interactive AI experience to deliver care that members can use anywhere, anytime, under a clinician’s supervision.

Catch

Seed Round in 2019
Catch is redesigning benefits to put people at the center of their own financial stability and security. For freelancers, contractors, and workers without access to employer benefits, Catch automatically handles tax withholding, builds long-term investment savings, and provides critical insurance products. In creating a personalized safety net, Catch envisions a world where individuals can leverage data-driven curation and timely insights to gain full agency over changing needs.

Siren Care

Series A in 2018
Siren Care is engaging with providers and payers to transform healthcare for chronic disease and aging. Our flagship program, the Siren Diabetic Foot Program, is a comprehensive service powered by our proprietary Siren Socks which monitor foot temperature continuously to deliver superior early detection of diabetic foot ulcers.

Remedy

Seed Round in 2018
Remedy is a prescriptive chronic care analytics platform employing artificial intelligence to help value-based health systems determine who should get what care, when, how, and by whom to maximize patient health outcomes per dollar spent. We are a design-driven company with core medical AI technology capable of diagnosing disease, catching hidden high-risk diagnoses, and projecting the development of patient’s health into the future. Built around our core AI engine, our first product Remedy Sentinel helps value-based providers identify hidden chronic, co-morbid conditions and intervene by engaging high-risk patients prior to onset. We envision a world where healthcare marries the science of “health” with the art of “care”: scientific, data-driven decision making drives the best outcomes for each individual patient, and frees providers to focus on applying their human touch. Remedy combines novel artificial intelligence algorithms for predictive medical analytics with a healthcare-optimized product development process to give leaders the tools they need to transform their delivery networks and thrive in a value-based care environment. With this approach, Remedy builds a scalable suite of products that, when deployed, learn from experience, and grow into a solution optimized to fit the needs of specific provider groups and the populations they serve. Remedy systematically maximizes the patient health outcome achieved with each dollar spent by using AI to help determine what care is delivered to whom, when it is delivered, where it is delivered, how it is delivered, followed, and supported, and who should deliver it. We not only surface insights, but also build the necessary tools and helps coordinate step-by-step implementation processes to affect real change.

Lumiata

Series B in 2018
Lumiata is transforming the healthcare enterprise through the application of AI. Bringing predictive power within reach of data science teams and business users, we’re driving predictability and precision at scale — empowering providers and payers to reduce risk and manage costs and move out of reliance on flat data into a future of insights. Lumiata machine learning tools and pre-trained models comprise a scalable platform purpose-built for healthcare. Lumiata products are built from more than 120 million patient records, in-depth clinical knowledge, and its proprietary clinical IP. Lumiata enables healthcare organizations to explore use cases such as underwriting and care management. Lumiata is proud to be backed by Khosla Ventures, Blue Venture Fund, Defy.vc, and AllegisNL Capital. Team Lumiata is distributed across Silicon Valley, Dallas, and Guadalajara, Mexico.

Zebra Medical Vision

Series C in 2018
Zebra Medical Vision Ltd. is a company that develops an imaging analytics platform aimed at enhancing patient care in healthcare institutions. Founded in 2014 and based in Shefayim, Israel, the platform utilizes advanced learning and computer vision algorithms to assist clinicians in identifying patients at risk of various diseases. This technology supports healthcare providers in implementing effective risk management and preventative care strategies. Zebra Medical Vision also supplies tools and datasets for machine-learning researchers, facilitating the rapid development of decision support tools and diagnostic solutions. The company has established strategic partnerships with organizations such as USARAD Holdings and TELUS Ventures, and has secured a total of $52 million in funding from notable investors, including Khosla Ventures and Nvidia. Its AI-driven products are FDA cleared and are utilized in hospitals across multiple regions, including the U.S., Europe, Australia, India, and Latin America, positioning Zebra Medical Vision as a leader in the field of medical imaging and analytics.

Curai Health

Series A in 2018
Curai is a virtual care company that uses artificial intelligence to provide chat-based primary care at a lower cost. It aims to make affordable, high-quality primary care accessible to everyone on the planet, whenever they want it. Founded by Neal Khosla and Xavier Amatriain in 2017, Curai Health offers chat-based primary care that combines clinicians with the industry's most advanced AI to create a learning healthcare system that increasingly slashes the cost of delivering high-quality care. Headquartered in Palo Alto, Curai Health is available directly to consumers or through enterprise partnerships.

Iora Health

Series E in 2018
Iora Health is dedicated to providing possible service and care for each patient without any of the barriers or excuses that plague the current system. They’ve completely redesigned Primary Care to help patients better manage their health and navigate the health care system. Every patient gets a personal physician as well as a personal health coach who stays in close contact during and between office visits, both of whom are available by email, text, or video in addition to in-person visits. In addition, they provide educational offerings, including group visits, to help patients stay on track with their health goals.

Siren Care

Seed Round in 2018
Siren Care is engaging with providers and payers to transform healthcare for chronic disease and aging. Our flagship program, the Siren Diabetic Foot Program, is a comprehensive service powered by our proprietary Siren Socks which monitor foot temperature continuously to deliver superior early detection of diabetic foot ulcers.

Oscar Health

Venture Round in 2018
Oscar Health is a health insurance company that offers a range of plans for individuals, families, and small groups, as well as Medicare Advantage options for adults aged 65 and older. Founded in 2012 by Joshua Kushner, Kevin Nazemi, and Mario Schlosser, the company is headquartered in New York City. Oscar Health employs technology and data-driven solutions to enhance the healthcare experience, providing virtual care, doctor support, and appointment scheduling services. Its plans are available in select regions of New York, New Jersey, California, and Texas, catering to those who do not receive employer-sponsored health insurance.

Clara Health

Seed Round in 2018
Clara Health operates a software platform aimed at simplifying the clinical trial process for patients. This platform assists individuals in navigating clinical trials by providing tools for protocol design, site selection, and adherence monitoring. It allows patients to filter through available clinical trials, facilitating their connection to relevant studies in a patient-centric manner. By streamlining these processes, Clara Health enhances the overall experience for patients seeking participation in clinical research.

DiscernDx

Seed Round in 2018
DiscernDx provides users with access to individual clinical and molecular data to proactively manage health and make informed decisions. The company offers regular health monitoring, early disease detection, and personalized care for every individual. DiscernDx was founded in 2017 and is based in Palo Alto, California.

Q Bio

Series A in 2018
Q Bio, founded in 2015 by Jeffrey Kaditz, Dr. Michael Snyder, and Dr. Garry Choy, operates a clinical digital twin platform aimed at assessing patients' medical histories to identify immediate and future health risks. Based in San Carlos, California, the company utilizes whole-body scans to create a digital twin of each patient's physical body, quantifying and digitizing health data. By leveraging simulated human physiology and machine learning, Q Bio's platform can predict potential health risks, enabling healthcare professionals to provide proactive treatment. The interdisciplinary team at Q Bio comprises experts in applied mathematics, computational physics, electrical engineering, genetics, and radiology, supported by prominent venture capital firms.

Olive

Series C in 2017
Olive AI, Inc. specializes in developing artificial intelligence and robotic process automation solutions tailored for healthcare organizations. Founded in 2012 and based in Columbus, Ohio, the company offers an AI-as-a-Service platform that automates a variety of administrative workflows, including claim status checks, account updates, and prior authorizations. By streamlining these repetitive and high-volume tasks, Olive allows healthcare professionals to focus on more creative and empathetic aspects of patient care. The software acts as an intermediary between different systems and data, helping to reduce administrative errors and improve cash collections, ultimately enhancing overall efficiency and patient outcomes in the healthcare sector. Olive AI, Inc. was previously known as CrossChx, Inc. before rebranding in July 2018.

Ellipsis Health

Seed Round in 2017
Ellipsis Health is an early-stage start-up developing affective computing for existing patient/care team interactions to create a real-time, behavioral health vital sign for each patient. It provides a simple, cost-effective way for health systems to continually screen their patient population for conditions such as depression and get patients the support they need.

Lumiata

Series A in 2017
Lumiata is transforming the healthcare enterprise through the application of AI. Bringing predictive power within reach of data science teams and business users, we’re driving predictability and precision at scale — empowering providers and payers to reduce risk and manage costs and move out of reliance on flat data into a future of insights. Lumiata machine learning tools and pre-trained models comprise a scalable platform purpose-built for healthcare. Lumiata products are built from more than 120 million patient records, in-depth clinical knowledge, and its proprietary clinical IP. Lumiata enables healthcare organizations to explore use cases such as underwriting and care management. Lumiata is proud to be backed by Khosla Ventures, Blue Venture Fund, Defy.vc, and AllegisNL Capital. Team Lumiata is distributed across Silicon Valley, Dallas, and Guadalajara, Mexico.

Catalia Health

Seed Round in 2017
Catalia Health brings together artificial intelligence, psychology, and medicine to deliver lasting change. We create effective patient engagement and generate unique data of value to our customers. Our cloud-based platform delivers unique conversations to patients to help address their ongoing healthcare issues in an effective way. These messages are delivered through mobile apps, a web interface, and our uniquely engaging (and patented) interactive robotic coach.

Cairns Health

Seed Round in 2017
Cairns Health is a digital care companion and enablement platform for senior living and home care. The company's digital care plan enablement solution integrates intelligent ambient sensing (radar), artificial intelligence (AI) and large language models (LLM's) to streamline caregiver-patient interactions, boost engagement, and empower patients with a better understanding of their care plans, leading to timely interventions that improve care while reducing overall care delivery costs.

Guardant Health

Series E in 2017
Guardant Health is committed to positively and significantly impacting patient health through technology breakthroughs that address long-standing unmet needs in oncology. Guardant is backed by Sequoia Capital, led by a seasoned management team comprising thought leaders and successful serial entrepreneurs in next-generation sequencing and rare-cell diagnostics, and is closely advised by an oncologist-led medical steering committee from leading cancer centers across North America and abroad.

Twine Health

Series A in 2017
Twine Health, Inc. is a healthcare technology company that specializes in a cloud-based platform aimed at chronic disease management. The platform facilitates collaborative care by integrating tools for shared decision-making, self-tracking, and communication between patients and their healthcare providers. Patients can co-create personalized care plans with their care teams, which may include physicians, nurses, family members, and health coaches. This collaborative approach is designed to enhance patient engagement and self-efficacy, ultimately leading to better health outcomes and reduced healthcare costs. Established in 2012 and based in Cambridge, Massachusetts, Twine Health was developed at the MIT Medical Lab and operates as a subsidiary of Fitbit, Inc. since 2018.

Catalia Health

Seed Round in 2017
Catalia Health brings together artificial intelligence, psychology, and medicine to deliver lasting change. We create effective patient engagement and generate unique data of value to our customers. Our cloud-based platform delivers unique conversations to patients to help address their ongoing healthcare issues in an effective way. These messages are delivered through mobile apps, a web interface, and our uniquely engaging (and patented) interactive robotic coach.

Medisas

Series A in 2016
Medisas is a team of experienced and passionate clinicians, engineers, designers reinventing hospital software.

PatientBank

Seed Round in 2016
PatientBank lets you request medical records online—from any doctor or hospital.

Caption Health

Series A in 2016
Caption Health, Inc. is a technology company that specializes in artificial intelligence-driven software solutions for ultrasound examinations. Founded in 2013 and headquartered in Brisbane, California, the company offers Caption AI, a system designed to assist healthcare providers in acquiring and interpreting ultrasound images. This software provides real-time guidance during exams, automates quality assessments, and facilitates the interpretation of ultrasound results, enabling practitioners to capture high-quality diagnostic images more efficiently. As the adoption of the Caption AI platform grows, Caption Health plans to enhance its technology and expand its clinical capabilities, aiming to integrate its solutions into a wider range of healthcare settings.

Vida Health

Series B in 2016
Vida Health is a virtual care platform intentionally designed to treat a person’s whole health by treating mental and physical conditions, together. Vida’s clinically validated approach combines an AI-powered, personalized experience with the support and human connection of coaches and therapists. Vida’s app offers video sessions, messaging, and digital content to help people prevent, manage, and reverse chronic conditions — like diabetes and hypertension — and the mental conditions that accompany them — like stress, depression, and anxiety. Some of America’s largest employers and health plans trust Vida’s whole health offering. The company was founded in 2014 and is based in San Francisco, California

Iora Health

Series D in 2016
Iora Health is dedicated to providing possible service and care for each patient without any of the barriers or excuses that plague the current system. They’ve completely redesigned Primary Care to help patients better manage their health and navigate the health care system. Every patient gets a personal physician as well as a personal health coach who stays in close contact during and between office visits, both of whom are available by email, text, or video in addition to in-person visits. In addition, they provide educational offerings, including group visits, to help patients stay on track with their health goals.

Color

Series B in 2016
Color is a complete platform for healthcare delivery from population genomics programs to high-throughput COVID-19 testing, Color provides the technology and infrastructure for large-scale health initiatives. Equitable, accessible healthcare programs. We bring together everything that’s required to run a large-scale healthcare program for your business, school, or state. Color’s products and services allow you to provide access to preventive healthcare programs whether your population is in one office or spread out across the country.

Lumiata

Series B in 2016
Lumiata is transforming the healthcare enterprise through the application of AI. Bringing predictive power within reach of data science teams and business users, we’re driving predictability and precision at scale — empowering providers and payers to reduce risk and manage costs and move out of reliance on flat data into a future of insights. Lumiata machine learning tools and pre-trained models comprise a scalable platform purpose-built for healthcare. Lumiata products are built from more than 120 million patient records, in-depth clinical knowledge, and its proprietary clinical IP. Lumiata enables healthcare organizations to explore use cases such as underwriting and care management. Lumiata is proud to be backed by Khosla Ventures, Blue Venture Fund, Defy.vc, and AllegisNL Capital. Team Lumiata is distributed across Silicon Valley, Dallas, and Guadalajara, Mexico.

Forward

Seed Round in 2016
Forward is a startup redesigning the way healthcare is delivered using all the technologies healthcare has neglected such as sensors, mobile, and AI. Forward was founded in January 2016 by former executives and engineering leaders from Google and Uber and led by serial entrepreneur Adrian Aoun. Forward is funded by investors and entrepreneurs including First Round Capital, Eric Schmidt (Google/Alphabet chairman), Marc Benioff (Salesforce founder), Joe Lonsdale (Palantir founder), Joshua Kushner (Oscar co-founder), and Garrett Camp (Uber co-founder).

Zebra Medical Vision

Series B in 2016
Zebra Medical Vision Ltd. is a company that develops an imaging analytics platform aimed at enhancing patient care in healthcare institutions. Founded in 2014 and based in Shefayim, Israel, the platform utilizes advanced learning and computer vision algorithms to assist clinicians in identifying patients at risk of various diseases. This technology supports healthcare providers in implementing effective risk management and preventative care strategies. Zebra Medical Vision also supplies tools and datasets for machine-learning researchers, facilitating the rapid development of decision support tools and diagnostic solutions. The company has established strategic partnerships with organizations such as USARAD Holdings and TELUS Ventures, and has secured a total of $52 million in funding from notable investors, including Khosla Ventures and Nvidia. Its AI-driven products are FDA cleared and are utilized in hospitals across multiple regions, including the U.S., Europe, Australia, India, and Latin America, positioning Zebra Medical Vision as a leader in the field of medical imaging and analytics.

Olive

Series C in 2016
Olive AI, Inc. specializes in developing artificial intelligence and robotic process automation solutions tailored for healthcare organizations. Founded in 2012 and based in Columbus, Ohio, the company offers an AI-as-a-Service platform that automates a variety of administrative workflows, including claim status checks, account updates, and prior authorizations. By streamlining these repetitive and high-volume tasks, Olive allows healthcare professionals to focus on more creative and empathetic aspects of patient care. The software acts as an intermediary between different systems and data, helping to reduce administrative errors and improve cash collections, ultimately enhancing overall efficiency and patient outcomes in the healthcare sector. Olive AI, Inc. was previously known as CrossChx, Inc. before rebranding in July 2018.

Oscar Health

Private Equity Round in 2016
Oscar Health is a health insurance company that offers a range of plans for individuals, families, and small groups, as well as Medicare Advantage options for adults aged 65 and older. Founded in 2012 by Joshua Kushner, Kevin Nazemi, and Mario Schlosser, the company is headquartered in New York City. Oscar Health employs technology and data-driven solutions to enhance the healthcare experience, providing virtual care, doctor support, and appointment scheduling services. Its plans are available in select regions of New York, New Jersey, California, and Texas, catering to those who do not receive employer-sponsored health insurance.

Guardant Health

Series D in 2016
Guardant Health is committed to positively and significantly impacting patient health through technology breakthroughs that address long-standing unmet needs in oncology. Guardant is backed by Sequoia Capital, led by a seasoned management team comprising thought leaders and successful serial entrepreneurs in next-generation sequencing and rare-cell diagnostics, and is closely advised by an oncologist-led medical steering committee from leading cancer centers across North America and abroad.

Twine Health

Series A in 2015
Twine Health, Inc. is a healthcare technology company that specializes in a cloud-based platform aimed at chronic disease management. The platform facilitates collaborative care by integrating tools for shared decision-making, self-tracking, and communication between patients and their healthcare providers. Patients can co-create personalized care plans with their care teams, which may include physicians, nurses, family members, and health coaches. This collaborative approach is designed to enhance patient engagement and self-efficacy, ultimately leading to better health outcomes and reduced healthcare costs. Established in 2012 and based in Cambridge, Massachusetts, Twine Health was developed at the MIT Medical Lab and operates as a subsidiary of Fitbit, Inc. since 2018.

CrowdMed

Seed Round in 2015
CrowdMed is revolutionizing healthcare by harnessing ‘the wisdom of crowds’ to help solve even the world’s most difficult medical cases quickly and accurately online. After 4 years of development and refinement, CrowdMed’s patented prediction market technology can uncover diagnoses to real-world medical cases that have stumped doctors for years. Instead of relying on individual physicians, CrowdMed harnesses the collective intelligence of thousands of Medical Detectives to produce astonishingly accurate and insightful diagnostic suggestions. Their goal is to be relied upon by millions of patients as a trusted source of medical answers. They combine the collective knowledge of human diagnosticians with the speed and convenience of the Internet.

Catalia Health

Seed Round in 2015
Catalia Health brings together artificial intelligence, psychology, and medicine to deliver lasting change. We create effective patient engagement and generate unique data of value to our customers. Our cloud-based platform delivers unique conversations to patients to help address their ongoing healthcare issues in an effective way. These messages are delivered through mobile apps, a web interface, and our uniquely engaging (and patented) interactive robotic coach.

Color

Series A in 2015
Color is a complete platform for healthcare delivery from population genomics programs to high-throughput COVID-19 testing, Color provides the technology and infrastructure for large-scale health initiatives. Equitable, accessible healthcare programs. We bring together everything that’s required to run a large-scale healthcare program for your business, school, or state. Color’s products and services allow you to provide access to preventive healthcare programs whether your population is in one office or spread out across the country.

Oscar Health

Series C in 2015
Oscar Health is a health insurance company that offers a range of plans for individuals, families, and small groups, as well as Medicare Advantage options for adults aged 65 and older. Founded in 2012 by Joshua Kushner, Kevin Nazemi, and Mario Schlosser, the company is headquartered in New York City. Oscar Health employs technology and data-driven solutions to enhance the healthcare experience, providing virtual care, doctor support, and appointment scheduling services. Its plans are available in select regions of New York, New Jersey, California, and Texas, catering to those who do not receive employer-sponsored health insurance.

Olive

Series B in 2015
Olive AI, Inc. specializes in developing artificial intelligence and robotic process automation solutions tailored for healthcare organizations. Founded in 2012 and based in Columbus, Ohio, the company offers an AI-as-a-Service platform that automates a variety of administrative workflows, including claim status checks, account updates, and prior authorizations. By streamlining these repetitive and high-volume tasks, Olive allows healthcare professionals to focus on more creative and empathetic aspects of patient care. The software acts as an intermediary between different systems and data, helping to reduce administrative errors and improve cash collections, ultimately enhancing overall efficiency and patient outcomes in the healthcare sector. Olive AI, Inc. was previously known as CrossChx, Inc. before rebranding in July 2018.

Zebra Medical Vision

Seed Round in 2015
Zebra Medical Vision Ltd. is a company that develops an imaging analytics platform aimed at enhancing patient care in healthcare institutions. Founded in 2014 and based in Shefayim, Israel, the platform utilizes advanced learning and computer vision algorithms to assist clinicians in identifying patients at risk of various diseases. This technology supports healthcare providers in implementing effective risk management and preventative care strategies. Zebra Medical Vision also supplies tools and datasets for machine-learning researchers, facilitating the rapid development of decision support tools and diagnostic solutions. The company has established strategic partnerships with organizations such as USARAD Holdings and TELUS Ventures, and has secured a total of $52 million in funding from notable investors, including Khosla Ventures and Nvidia. Its AI-driven products are FDA cleared and are utilized in hospitals across multiple regions, including the U.S., Europe, Australia, India, and Latin America, positioning Zebra Medical Vision as a leader in the field of medical imaging and analytics.

Guardant Health

Series C in 2015
Guardant Health is committed to positively and significantly impacting patient health through technology breakthroughs that address long-standing unmet needs in oncology. Guardant is backed by Sequoia Capital, led by a seasoned management team comprising thought leaders and successful serial entrepreneurs in next-generation sequencing and rare-cell diagnostics, and is closely advised by an oncologist-led medical steering committee from leading cancer centers across North America and abroad.

Caption Health

Seed Round in 2015
Caption Health, Inc. is a technology company that specializes in artificial intelligence-driven software solutions for ultrasound examinations. Founded in 2013 and headquartered in Brisbane, California, the company offers Caption AI, a system designed to assist healthcare providers in acquiring and interpreting ultrasound images. This software provides real-time guidance during exams, automates quality assessments, and facilitates the interpretation of ultrasound results, enabling practitioners to capture high-quality diagnostic images more efficiently. As the adoption of the Caption AI platform grows, Caption Health plans to enhance its technology and expand its clinical capabilities, aiming to integrate its solutions into a wider range of healthcare settings.

Iora Health

Series C in 2015
Iora Health is dedicated to providing possible service and care for each patient without any of the barriers or excuses that plague the current system. They’ve completely redesigned Primary Care to help patients better manage their health and navigate the health care system. Every patient gets a personal physician as well as a personal health coach who stays in close contact during and between office visits, both of whom are available by email, text, or video in addition to in-person visits. In addition, they provide educational offerings, including group visits, to help patients stay on track with their health goals.

Ginger

Series B in 2014
Ginger.io, Inc. is a digital mental health provider that offers a behavioral analytics platform designed to deliver on-demand mental healthcare via mobile devices. Founded in 2010 and headquartered in San Francisco, California, the platform connects users with a team of behavioral health coaches, therapists, and psychiatrists, facilitating personalized care accessible 24/7. Users can collect and analyze both passive and active behavioral data, enabling the identification of health insights and deviations from normal behavior. This service is utilized by a wide range of clients, including researchers, healthcare providers, and millions of employees through partnerships with leading employers and health plans. Ginger's approach focuses on providing immediate support and evidence-based interventions for individuals experiencing mental health challenges such as depression and anxiety.

Vida Health

Series A in 2014
Vida Health is a virtual care platform intentionally designed to treat a person’s whole health by treating mental and physical conditions, together. Vida’s clinically validated approach combines an AI-powered, personalized experience with the support and human connection of coaches and therapists. Vida’s app offers video sessions, messaging, and digital content to help people prevent, manage, and reverse chronic conditions — like diabetes and hypertension — and the mental conditions that accompany them — like stress, depression, and anxiety. Some of America’s largest employers and health plans trust Vida’s whole health offering. The company was founded in 2014 and is based in San Francisco, California

Oscar Health

Series B in 2014
Oscar Health is a health insurance company that offers a range of plans for individuals, families, and small groups, as well as Medicare Advantage options for adults aged 65 and older. Founded in 2012 by Joshua Kushner, Kevin Nazemi, and Mario Schlosser, the company is headquartered in New York City. Oscar Health employs technology and data-driven solutions to enhance the healthcare experience, providing virtual care, doctor support, and appointment scheduling services. Its plans are available in select regions of New York, New Jersey, California, and Texas, catering to those who do not receive employer-sponsored health insurance.

Guardant Health

Series B in 2014
Guardant Health is committed to positively and significantly impacting patient health through technology breakthroughs that address long-standing unmet needs in oncology. Guardant is backed by Sequoia Capital, led by a seasoned management team comprising thought leaders and successful serial entrepreneurs in next-generation sequencing and rare-cell diagnostics, and is closely advised by an oncologist-led medical steering committee from leading cancer centers across North America and abroad.

Lumiata

Series A in 2014
Lumiata is transforming the healthcare enterprise through the application of AI. Bringing predictive power within reach of data science teams and business users, we’re driving predictability and precision at scale — empowering providers and payers to reduce risk and manage costs and move out of reliance on flat data into a future of insights. Lumiata machine learning tools and pre-trained models comprise a scalable platform purpose-built for healthcare. Lumiata products are built from more than 120 million patient records, in-depth clinical knowledge, and its proprietary clinical IP. Lumiata enables healthcare organizations to explore use cases such as underwriting and care management. Lumiata is proud to be backed by Khosla Ventures, Blue Venture Fund, Defy.vc, and AllegisNL Capital. Team Lumiata is distributed across Silicon Valley, Dallas, and Guadalajara, Mexico.

Oscar Health

Series A in 2014
Oscar Health is a health insurance company that offers a range of plans for individuals, families, and small groups, as well as Medicare Advantage options for adults aged 65 and older. Founded in 2012 by Joshua Kushner, Kevin Nazemi, and Mario Schlosser, the company is headquartered in New York City. Oscar Health employs technology and data-driven solutions to enhance the healthcare experience, providing virtual care, doctor support, and appointment scheduling services. Its plans are available in select regions of New York, New Jersey, California, and Texas, catering to those who do not receive employer-sponsored health insurance.

Embrace Global

Series A in 2013
Embrace Global is a healthcare technology company based in Bengaluru, India, focused on developing and distributing affordable medical devices aimed at reducing infant and maternal mortality in emerging markets. The company is known for its innovative product, Embrace Nest, a portable infant warmer designed for low birth-weight and premature babies. This device, which is significantly more affordable than traditional incubators, addresses the critical need for effective care solutions in regions where access to advanced medical equipment is limited. Embrace Global also engages in research and development to create new low-cost health innovations that enhance maternal and child health outcomes.

Oscar Health

Series A in 2013
Oscar Health is a health insurance company that offers a range of plans for individuals, families, and small groups, as well as Medicare Advantage options for adults aged 65 and older. Founded in 2012 by Joshua Kushner, Kevin Nazemi, and Mario Schlosser, the company is headquartered in New York City. Oscar Health employs technology and data-driven solutions to enhance the healthcare experience, providing virtual care, doctor support, and appointment scheduling services. Its plans are available in select regions of New York, New Jersey, California, and Texas, catering to those who do not receive employer-sponsored health insurance.

CrowdMed

Seed Round in 2013
CrowdMed is revolutionizing healthcare by harnessing ‘the wisdom of crowds’ to help solve even the world’s most difficult medical cases quickly and accurately online. After 4 years of development and refinement, CrowdMed’s patented prediction market technology can uncover diagnoses to real-world medical cases that have stumped doctors for years. Instead of relying on individual physicians, CrowdMed harnesses the collective intelligence of thousands of Medical Detectives to produce astonishingly accurate and insightful diagnostic suggestions. Their goal is to be relied upon by millions of patients as a trusted source of medical answers. They combine the collective knowledge of human diagnosticians with the speed and convenience of the Internet.

HealthTap

Series B in 2013
HealthTap is a virtual-first, affordable urgent and primary care clinic, providing top-quality physician care equitably nationwide to all Americans, with or without insurance.

Medisas

Seed Round in 2013
Medisas is a team of experienced and passionate clinicians, engineers, designers reinventing hospital software.

Ginger

Series A in 2012
Ginger.io, Inc. is a digital mental health provider that offers a behavioral analytics platform designed to deliver on-demand mental healthcare via mobile devices. Founded in 2010 and headquartered in San Francisco, California, the platform connects users with a team of behavioral health coaches, therapists, and psychiatrists, facilitating personalized care accessible 24/7. Users can collect and analyze both passive and active behavioral data, enabling the identification of health insights and deviations from normal behavior. This service is utilized by a wide range of clients, including researchers, healthcare providers, and millions of employees through partnerships with leading employers and health plans. Ginger's approach focuses on providing immediate support and evidence-based interventions for individuals experiencing mental health challenges such as depression and anxiety.

Zocdoc

Series C in 2011
Zocdoc is a technology company that provides a better healthcare experience for millions of patients every month. Its online marketplace delivers the accessible, seamless, and simple experience patients expect and deserve. Zocdoc was founded in 2007 and is headquartered in New York.

Zocdoc

Series B in 2010
Zocdoc is a technology company that provides a better healthcare experience for millions of patients every month. Its online marketplace delivers the accessible, seamless, and simple experience patients expect and deserve. Zocdoc was founded in 2007 and is headquartered in New York.

Zocdoc

Series A in 2008
Zocdoc is a technology company that provides a better healthcare experience for millions of patients every month. Its online marketplace delivers the accessible, seamless, and simple experience patients expect and deserve. Zocdoc was founded in 2007 and is headquartered in New York.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.